2026 AOSSM Annual Meeting Recordings

Information

Please Note: The Q&A QR code in the Recordings is currently inactive. Any questions submitted through it will not be monitored or answered.

The 2026 AOSSM Annual Meeting is the premier continuing medical education (CME) event for orthopaedic sports medicine professionals. Held annually, this dynamic gathering attracts leading physicians, athletic trainers, physical therapists, physician associates, elite athletes, and global experts committed to advancing the field of sports medicine. The program offers a rich blend of educational opportunities, including instructional courses, scientific podium and concurrent sessions, e-posters, and cutting-edge research presentations. Signature events such as the Residents and Fellows Forum and the Research Workshop provide specialized engagement for early-career professionals and researchers. Designed to foster learning, collaboration, and innovation, the meeting equips attendees with the latest knowledge and techniques to enhance the care of athletes of all ages and levels of play.

This content is also available without CME HERE.

Educational Objectives

By participating in this CME activity, the learner will be able to:

Evaluate and apply the latest evidence-based surgical and non-surgical techniques in the diagnosis, treatment, and rehabilitation of sports-related musculoskeletal injuries across diverse patient populations.

Incorporate emerging research, biologic therapies, and advanced technologies into clinical decision-making to improve outcomes and enhance performance and recovery in athletic patients.

Demonstrate improved interdisciplinary collaboration by integrating insights from orthopaedic surgery, physical therapy, athletic training, and related specialties to deliver comprehensive, athlete-centered care.

CANCELLATION/REFUND POLICY

There are no refunds for this online enduring material.

Additional Information

Accreditation

ACCREDITATION STATEMENT The American Orthopaedic Society for Sports Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Information
ABOS MOC CREDIT STATEMENT: Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME requirements of the American Board of Orthopaedic Surgery’s (ABOS) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABOS credit.

AMA CREDIT DESIGNATION STATEMENT The American Orthopaedic Society for Sports Medicine designates this enduring material for a maximum of 31 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CLAIMING CREDIT In order to obtain AMA PRA Category 1 Credit™ participants must complete the activity and online evaluation. No hard copy submissions will be accepted.

American Orthopaedic Society for Sports Medicine (AOSSM) (BOC AP# P460) is approved by the Board of Certification, Inc. to provide continuing education to Athletic Trainers. This program is eligible for a maximum of 31 Category A CEUs. ATs should claim only those hours actually spent in the educational program.

Disclosures

Planners

Marisol Claich
has no relevant financial relationship(s) with ineligible companies to disclose

Rachel Frank, MD
Arthrex Inc: Consultant (Ongoing)|Arthrex Inc: Researcher (Ongoing)|Arthrex Inc:
Speaker (Ongoing)|JRF Ortho: Other (Ongoing)|JRF Ortho: Researcher (Ongoing)|Stryker:
Speaker (Ongoing)

Armando Vidal, MD
Bodycad: Consultant (Ongoing)|Bodycad: Own stock options in a privately held
ineligible company (Ongoing)|Bodycad: Royalties (Ongoing)|Stryker Sports Medicine:
Consultant (Ongoing)|Stryker Sports Medicine: Royalties (Ongoing)|Stryker Sports
Medicine: Speaker (Ongoing)

Faculty

The following Faculty "has no relevant financial relationship(s) with ineligible companies to disclose"

Lutul D. Farrow, MD

Matthew Salzler, MD

Kehinde S. Agoro, MD

Melissa Albersheim, MD

Alyssa Althoff, MD

Justin Arner, MD

Geoffery S. Baer, MD,PhD

Abigail Balsan, BS

Andrew B. Barcenas, BS

Miles Batty, MD

Stephania Bell

Craig Bennett, MD

Robert E. Bilodeau, BS

Meghan Bishop, MD

Eric Bowman, MD

Taylor K. Calibo, MS

Kenneth L. Cameron, PhD, MPH, ATC

Christpher Camp, MD

Kirk A. Campbell, MD

Eric W. Carson, MD

James B. Carr, MD

Ting Cong, MD

Diego Cordero, MD

Sahil Dadoo, MD

Jade Dai, BA

Lucas De Virgilio, MD

Taku Ebata, MD, PhD

Neal ElAttrache, MD

Michael Ellman, MD

Brian Feeley, MD

Francisco Figueroa, MD

Peter M. Fites, MD

Jonathan Finnoff, MD

Heath P. Gould, MD

W. Jeffrey Grantham, MD

Zachary Herman, MD

Benton Heyworth, MD

Eoghan T. Hurley, PhD, MBBCH

Peter Indelicato, MD

Ami Kapadia, MD

John D. Kelly, MD

Vincent H. Key, MD

Professor Baris Kocaoglu, MD

Michael J. Kutschke, MD

Nathanial W. Linstrom, BS

Christian Lozano, MD

Anton Mantitiu, MD

Takehiko Matsushita, MD, PhD

Sophia McMahon, BA

Lucy Meyer, MD

Jacob D. Mikula, MD

Matthew D. Milewski, MD

Tonatiuh Mondragon, MD

Maximilian M. Mueller, MD

Volker Mushal, MD

Tim Nicolello,MS, ATC

Kyle Obana

Yuki Okazaki, MD

Abdulganeey Olawin, BS

Michael Ong, MD

Andrea Palazzolo Ray, MD, PhD

Athanasios V. Papvasileious, MSc, MD, PhD

Jack Paradis, BA

Romir Patel, MD

Mark V. Paterno, MD

J. Christian Peterson, MD

Sridhar Pinnamaneni, MD

Sourav Poddar, MD

Alexander E. Poor, MD

Rachel L. Poutre, MD

Robert Prill,MD

Trai Promsang, MD

Omar A. Protzuk, MD

Anil S. Ranawat, MD

Pietro S. Randelli, MD

James Ross, MD

Ajay Shah, MD

Michelle Shen, MD

Alex Smith

Jeffrey Smith MD

Jennifer Smith MD

Yasushi Takata MD, PhD

Tyler Teurlings, MD

Grant Thomas, MD

David Torres, MD

Alison P. Toth, MD

Akira Tsujii, MD, PhD

Tyler J. Uppstrom, MD

Ajit Vakharia, MD

Jalen Warren, DO

Alexander White, MD

Zachariah Whiting, MD

Kevin Wilk, MD

Riley J. Williams, MD

Michelle Wolcott, MD

Joseph Yellin, MD

Christopher Ahmad, MD

Arthrex: Consultant (Ongoing)|Arthrex: Royalties (Ongoing)

Michael Alaia, MD

Arthrex: Consultant (Ongoing)|Body Cad: Consultant (Ongoing)|Cervos: Paid Advisor (Ongoing)|Overture: Own stock options in a privately held ineligible company (Ongoing)

Ned Amendola, MD

Arc Techtonics: Own stock options in a privately held ineligible company (Ongoing)|Arthrex Inc: Consultant (Ongoing)|Arthrex Inc: Royalties (Ongoing)|Bone Solutions: Consultant (Ongoing)|Bone Solutions: Own stock options in a privately held ineligible company (Ongoing)|MIACH: Own stock options in a privately held ineligible company (Ongoing)|Rubber City Bracing: Own stock options in a privately held ineligible company (Ongoing)|Stryker: Researcher (Ongoing)|Vericel: Researcher (Ongoing)

Asheesh Bedi, MD

Arthrex Inc: Consultant (Ongoing)|Arthrex Inc: Royalties (Ongoing)

Julie Bishop, MD

Arthrex: Consultant (Ongoing)|Stryker: Consultant (Ongoing)|Stryker: Speaker (Ongoing)

Nicolas Bonin, MD

Arthrex: Consultant (Ongoing)|Arthrex: Speaker (Ongoing)|ConMed: Royalties (Ongoing)|dedienne Sante: Royalties (Ongoing)|Stryker: Consultant (Ongoing)|Stryker: Speaker (Ongoing)

Kevin Bonner, MD

Arthrex Inc: Royalties (Ongoing)|DePuy Mitek: Royalties (Ongoing)|DePuy Mitek: Speaker (Ongoing)|LifeNet Health: Consultant (Ongoing)|LifeNet Health: Paid Advisor (Ongoing)|Zimmer Biomet: Consultant (Ongoing)|Zimmer Biomet: Own stock or stock options in a publicly traded ineligible company (Ongoing)|Zimmer Biomet: Royalties (Ongoing)|Zimmer Biomet: Speaker (Ongoing)

Jacqueline Brady, MD

MIACH: Speaker (Ongoing)

Jonathan Bravman, MD

Enovis: Consultant (Ongoing)|Shukla Medical: Consultant (Ongoing)|Shukla Medical: Royalties (Ongoing)|Smith&Nephew: Consultant (Ongoing)

Stephen Brockmeier, MD

Advita: Consultant (Terminated, July 1, 2025)|Advita: Royalties (Terminated, July 1, 2025)|Advita: Speaker (Terminated, July 1, 2025)|Arthrex: Consultant (Ongoing)|Arthrex: Royalties (Ongoing)|Arthrex: Speaker (Ongoing)|Zimmer Biomet: Royalties (Ongoing)

Robert Brophy, MD

Rejoni: Own stock options in a privately held ineligible company (Ongoing)|StatDx: Own stock options in a privately held ineligible company (Ongoing)|Syneos Anika: Speaker (Terminated, April 26, 2026)|Tulavi: Own stock options in a privately held ineligible company (Ongoing)

Leah Brown, MD

Johnson & Johnson MedTech: Consultant (Ongoing)|KiriGenX: Consultant (Ongoing)|KiriGenX: Own stock options in a privately held ineligible company (Ongoing)|(Ongoing)|Subchondral Solutions: Own stock options in a privately held ineligible company (Ongoing)

Brian Busconi, MD

Arthrex: Consultant (Ongoing)|DePuy Mitek: Consultant (Ongoing)|Pacira: Consultant (Ongoing)

E. Lyle Cain, MD

Arthrex, Inc: Consultant (Ongoing)|Arthrex, Inc: Royalties (Ongoing)

Peter Chalmers, MD

Advita: Consultant (Ongoing)|Advita: Royalties (Ongoing)|Advita: Speaker (Ongoing)|Cinch: Own stock options in a privately held ineligible company (Ongoing)|Depuy: Consultant (Ongoing)|Depuy: Royalties (Ongoing)|Depuy: Speaker (Ongoing)|MLB: Independent Contractor (Ongoing)|Responsive Arthroscopy: Royalties (Ongoing)|TitinKM Biomedical: Own stock options in a privately held ineligible company (Ongoing)

Steven Cohen, MD

Taylor and Francis: Royalties (Ongoing)

Brian Cole, MD

Arthrex, Inc: Consultant (Ongoing)|Arthrex, Inc: Researcher (Ongoing)|Arthrex, Inc: Royalties (Ongoing)|Ossio: Own stock options in a privately held ineligible company (Ongoing

Katherine Coyner, MD, MBA

Arthrex, Inc: Consultant (Ongoing)|Smith & Nephew: Speaker (Ongoing)

Travis Dekker, MD

Arthrex: Consultant (Ongoing)|Arthrex: Speaker (Ongoing)

Patrick Denard, MD

Arthrex, Inc: Consultant (Ongoing)|Arthrex, Inc: Researcher (Ongoing)|Arthrex, Inc: Royalties (Ongoing)|Complete Surgical Nutrition: Own stock options in a privately held ineligible company (Ongoing)|Pacira: Speaker (Ongoing)|Zurimed: Own stock options in a privately held ineligible company (Ongoing)

Elizabeth Dennis, MD, MS

Arthrex: Consultant (Ongoing)|ConMed: Consultant (Ongoing)

Wiemi Douoguih, MD

Arthrex Inc: Consultant (Ongoing)|Arthrex Inc: Researcher (Ongoing)|Arthrex Inc: Speaker (Ongoing)|New Clip Technics: Consultant (Ongoing)|New Clip Technics: Researcher (Ongoing)|New Clip Technics: Speaker (Ongoing)

Jason Dragoo, MD

APEX Biologix: Consultant (Ongoing)|Arthrex Inc: Consultant (Ongoing)|Averitas: Consultant (Ongoing)|Bioventus LLC: Consultant (Ongoing)|CAREStream: Consultant (Ongoing)|ConMed: Consultant (Ongoing)|MoxImed: Consultant (Ongoing)|Musculoskeletal Transplant Foundation: Consultant (Ongoing)|Organogenesis: Consultant (Ongoing)|Ossur: Consultant (Ongoing)|RTI Surgical: Researcher (Ongoing)|Zimmer Biomet: Researcher (Ongoing)

Jeffrey Dugas, MD

Arthrex: Researcher (Ongoing)|Arthrex: Royalties (Ongoing)|Arthrex: Speaker (Ongoing)|Smith & Nephew: Researcher (Ongoing)|Topical Gear: Own stock options in a privately held ineligible company (Ongoing)|Topical Gear: Royalties (Ongoing)

Sara Edwards, MD

Enovis: Consultant (Ongoing)|Zimmer Biomet: Consultant (Ongoing)

Claire Eliasberg, MD

Blue Box Docs, LLC: Speaker (Ongoing)|JEASO: Speaker (Ongoing)

Henry Ellis, MD

Arthrex, Inc: Speaker (Ongoing)|Avanos Medical: Speaker (Terminated)|DJO: Speaker (Terminated)|Orthopediatrics: Speaker (Ongoing)|Pylant Medical: Speaker (Ongoing)|Smith & Nephew: Speaker (Ongoing)|Stryker: Speaker (Ongoing)

Brandon Erickson, MD

Arthrex, Inc: Consultant (Ongoing)|Smith & Nephew: Consultant (Ongoing)

Justin Ernat, MD

johnson and johnson: Consultant (Ongoing)|Stryker Sports Medicine: Consultant (Ongoing)

Kevin W. Farmer, MD

Arthrex, Inc: Consultant (Ongoing)|Arthrex, Inc: Researcher (Ongoing)

Eric I. Ferkel, MD

Arthrex: Consultant (Ongoing)|Arthrex: Speaker (Ongoing)|Ossio: Consultant (Ongoing)|Ossio: Paid Advisor (Ongoing)|Ossio: Royalties (Ongoing)|Ossio: Speaker (Ongoing)|Smith & Nephew: Consultant (Ongoing)|Smith & Nephew: Speaker (Ongoing)|Zimmer Biomet: Consultant (Ongoing)|Zimmer Biomet: Speaker (Ongoing)

Brian Forsythe, MD
iBrainTech: Own stock options in a privately held ineligible company (Ongoing)|Zuno Medical: Own stock options in a privately held ineligible company (Ongoing)

Rachel Frank, MD

Arthrex Inc: Consultant (Ongoing)|Arthrex Inc: Researcher (Ongoing)|Arthrex Inc: Speaker (Ongoing)|JRF Ortho: Other (Ongoing)|JRF Ortho: Researcher (Ongoing)|Stryker: Speaker (Ongoing)

Michael Freehill, MD

Grant Garcia, MD

Arthrex Inc: Consultant (Ongoing)|Arthrex Inc: Paid Advisor (Ongoing)|Arthrex Inc: Speaker (Ongoing)|New Clip Technics: Consultant (Ongoing)|New Clip Technics: Speaker (Ongoing)|Vericel: Consultant (Ongoing)|Vericel: Paid Advisor (Ongoing)|Vericel: Speaker (Ongoing)

Jonathan Godin, MD

Arthrex: Consultant (Ongoing)|Arthrex: Researcher (Ongoing)|ConMed: Researcher (Ongoing)|Stryker: Consultant (Ongoing)ed: Consultant (Ongoing)|MoxImed: Royalties (Ongoing)|Smith & Nephew: Consultant (Ongoing)

Andreas Gomoll, MD

MoxImed: Consultant (Ongoing)|MoxImed: Royalties (Ongoing)|Smith & Nephew: Consultant (Ongoing)

Bonnie Gregory, MD

Arthrex Inc: Consultant (Ongoing)|Arthrex Inc: Speaker (Ongoing)

F. Winston Gwathmey, MD

Allosource: Consultant (Ongoing)| Stryker Sports Medicine: Consultant (Ongoing)|Stryker Sports Medicine: Paid Advisor (Ongoing)|Stryker Sports Medicine: Speaker (Ongoing)

Thomas Hackett, MD

Arthrex: Consultant (Ongoing)|NICE: Consultant (Ongoing)

Mia Hagen, MD

RTI Surgical: Consultant (Ongoing)|Smith & Nephew: Consultant (Ongoing)|Smith & Nephew: Speaker (Ongoing)

Sommer Hammoud, MD

Arthrex: Consultant (Ongoing)|Arthrex: Speaker (Ongoing)

Joshua Harris, MD

SLACK, Inc.: Royalties (Ongoing)|Smith & Nephew: Consultant (Ongoing)|Thieme, Inc: Royalties (Ongoing)

Jeffrey Hassebrock, MD

Smith & Nephew: Consultant (Ongoing)|Stryker: Consultant (Ongoing)

C. Thomas Haytmanek, MD

Arthrex Inc: Consultant (Ongoing)|Stryker: Researcher (Ongoing)

Mario Hevesi, MD PhD

MoxImed: Consultant (Ongoing)|Stryker Sports Medicine: Consultant (Ongoing)|Stryker Sports Medicine: Speaker (Ongoing)

Jerry Huang, MD

Acumed: Consultant (Ongoing)|Ossio: Consultant (Ongoing)|Restor3D: Consultant (Terminated, June 16, 2026)|Stryker: Consultant (Ongoing)

Kenneth Hunt, MD

Arthrex: Consultant (Ongoing)|Arthrex: Other (Ongoing)

J. Benjamin Jackson, MD, MBA

Vilex: Consultant (Ongoing)|Vilex: Royalties (Ongoing)

Laith Jazrawi, MD

Body Cad: Consultant (Ongoing)|johnson and johnson: Consultant (Ongoing)|Lazurite: Own stock options in a privately held ineligible company (Ongoing)|MIACH: Consultant (Ongoing)|Smith and Nephew: Consultant (Ongoing)

Timothy Johnson, MD

Tigon Medical: Consultant (Ongoing)

Deryk Jones, MD

Conmed: Consultant (Ongoing)|Conmed: Paid Advisor (Ongoing)|Conmed: Researcher (Ongoing)|Conmed: Speaker (Ongoing)|Depuy Synthes: Consultant (Ongoing)|Depuy Synthes: Paid Advisor (Ongoing)|Icarus: Speaker (Ongoing)|Vericel: Consultant (Ongoing)|Vericel: Paid Advisor (Ongoing)|Vericel: Researcher (Ongoing)|Vericel: Speaker (Ongoing)

Grant Jones, MD

Arthrex: Speaker (Ongoing)|Musculoskeletal Transplant Foundation: Consultant (Ongoing)

Anish Kadakia, MD

Arthrex, Inc: Consultant (Ongoing)|Arthrex, Inc: Researcher (Ongoing)|Arthrex, Inc: Royalties (Ongoing)|Arthrex, Inc: Speaker (Ongoing)

Michelle Kew, MD

Recovery Shop: Speaker (Ongoing)

Hideyuki Koga, MD PhD

Arthrex: Consultant (Ongoing)|Arthrex: Speaker (Ongoing)|Osferion Biomaterial: Consultant (Ongoing)|Osferion Biomaterial: Researcher (Ongoing)|Osferion Biomaterial: Speaker (Ongoing)|Smith & Nephew: Researcher (Ongoing)|Smith & Nephew: Speaker (Ongoing)|Stryker: Researcher (Ongoing)|Zimmer Biomet: Researcher (Ongoing)|Zimmer Biomet: Speaker (Ongoing)

Aaron Krych, MD

Arthrex, Inc: Consultant (Ongoing)|Arthrex, Inc: Royalties (Ongoing)

Andrew W. Kuhn, MD

SplintBox: Speaker (Ongoing)

Christopher Larson, MD

Responsive Arthroscopy: Consultant (Ongoing)|Responsive Arthroscopy: Own stock options in a privately held ineligible company (Ongoing)|Smith & Nephew: Consultant (Ongoing)

Christian Latterman, MD

aesculap: Paid Advisor (Ongoing)|Organogenesis: Paid Advisor (Ongoing)|Vericel: Consultant (Ongoing)

Brian C. Lau, MD

Arthrex: Speaker (Ongoing)|Cytek: Consultant (Ongoing)|Cytek: Own stock options in a privately held ineligible company (Ongoing)|MIACH: Consultant (Ongoing)|Newclip: Consultant (Ongoing)|Newclip: Royalties (Ongoing)

Lance LeClere, MD

Arthrex, Inc: Consultant (Ongoing)|Vericel: Consultant (Ongoing)

Cassandra Lee, MD

Medipost: Consultant (Ongoing)|Medipost: Paid Advisor (Ongoing)|Medipost: Researcher (Ongoing)|MoxImed: Consultant (Ongoing)|MoxImed: Researcher (Ongoing)|MoxImed: Speaker (Ongoing)|Smith and Nephew: Consultant (Ongoing)|Vericel: Consultant (Ongoing)|Vericel: Speaker (Ongoing)

Albert Lin, MD

Arthrex: Consultant (Ongoing)|Arthrex: Paid Advisor (Ongoing)|Arthrex: Royalties (Ongoing)|Arthrex: Speaker (Ongoing)|restor3d: Speaker (Ongoing)|Stryker: Consultant (Ongoing)|Stryker: Paid Advisor (Ongoing)

Joseph Liu, MD

OSSIO: Speaker (Ongoing)

Catherine Logan, MD, MBA

Arthrex: Consultant (Ongoing)|MIACH: Consultant (Ongoing)

Walter Lowe, MD

Arthrex, Inc: Consultant (Ongoing)|Arthrex, Inc: Royalties (Ongoing)

Travis G. Maak, MD

Arthrex, Inc: Consultant (Ongoing)|Arthrex, Inc: Speaker (Ongoing)

Chaitu Malempati, MD

Reparel: Consultant (Ongoing)|Reparel: Researcher (Ongoing)|Reparel: Speaker (Ongoing)|Smith & Nephew: Consultant (Ongoing)|Smith & Nephew: Researcher (Ongoing)|Smith & Nephew: Speaker (Ongoing)

Bert Mandelbaum, MD

APEX Biologix: Consultant (Ongoing)|Arthrex: Consultant (Ongoing)

Kevin Martin, MD

Arthrex: Consultant (Ongoing)|ConMed: Royalties (Ongoing)

Robert G. Marx, MD

MEND Nutrition: Consultant (Ongoing)

Richard Mather, MD, MBA

Stryker Sports Medicine: Consultant (Ongoing)|Stryker Sports Medicine: Royalties (Ongoing)

Elizabeth Matzkin, MD

Arthrex: Speaker (Ongoing)

Augustus Mazzocca, MS, MD

Arthrex, Inc: Consultant (Ongoing)|Arthrex, Inc: Researcher (Ongoing)|restor3d: Consultant (Ongoing)|restor3d: Own stock options in a privately held ineligible company (Ongoing)

Eric C. McCarty, MD

Arthrex, Inc: Researcher (Ongoing)|Bioventus LLC: Consultant (Ongoing)|BREG: Researcher (Ongoing)|DePuy Mitek: Researcher (Ongoing)|DJO: Researcher (Ongoing)|NICE: Paid Advisor (Ongoing)|Ossur: Researcher (Ongoing)|Smith & Nephew: Researcher (Ongoing)|Zimmer Biomet: Consultant (Ongoing)|Zimmer Biomet: Royalties (Ongoing)

Mark Miller, MD PE Col USAF Ret

Arthrex, Inc: Royalties (Ongoing)

Peter Millet, MD

Arthrex Inc: Consultant (Ongoing)|Arthrex inc.: Researcher (Ongoing)|Arthrex inc: Royalties (Ongoing)|VuMedi: Own stock options in a privately held ineligible company. (Ongoing)

Mary Mulcahey, MD

Arthrex, Inc: Consultant (Ongoing)|Depuy Synthes: Consultant (Ongoing)

Kanto Nagai, MD, PhD

Astellas: Speaker (Terminated, February 25, 2026)|AUSPICIOUS Co., Ltd.: Speaker (Ongoing)|Japan Tissue Engineering Co., Ltd.: Paid Advisor (Ongoing)|Smith & Nephew: Consultant (Ongoing)

Jeffrey Nepple, MD

Smith and Nephew: Consultant (Ongoing)|Smith and Nephew: Researcher (Ongoing)|Smith and Nephew: Speaker (Ongoing)|Stryker: Researcher (Ongoing)|Zimmer Biomet: Researcher (Ongoing)

Shane Nho, MD, MS

Stryker: Consultant (Ongoing)|Stryker: Researcher (Ongoing)|Stryker: Royalties (Ongoing)

Gabriella Ode, MD

Advita: Consultant (Ongoing)|Advita: Speaker (Ongoing)|Smith & Nephew: Speaker (Ongoing)

Kelechi Okohora, MD

Fx: Consultant (Ongoing)|Smith & Nephew: Consultant (Ongoing)

Daryl Osbahr, MD

Arthrex, Inc: Consultant (Ongoing)|Arthrex, Inc: Researcher (Ongoing)|Arthrex, Inc: Speaker (Ongoing)|Enovis: Consultant (Ongoing)|Expanded Existence: Consultant (Ongoing)|Expanded Existence: Own stock options in a privately held ineligible company (Ongoing)|GRD Innovations: Own stock options in a privately held ineligible company (Ongoing)|MIACH: Consultant (Terminated)|MIACH: Researcher (Terminated)|MIACH: Speaker (Terminated)|NESTRE: Consultant (Ongoing)|NESTRE: Own stock options in a privately held ineligible company (Ongoing)|Pinotage: Own stock options in a privately held ineligible company (Ongoing)|Proteqt365: Consultant (Ongoing)|Proteqt365: Own stock options in a privately held ineligible company (Ongoing)|Proteqt365: Paid Advisor (Ongoing)|TracPatch: Consultant (Ongoing)|TracPatch: Own stock options in a privately held ineligible company (Ongoing)

Brett Owens, MD

ConMed: Royalties (Ongoing)

Robert L. Parisien, MD

Arthrex Inc: Consultant (Ongoing)|Vericel: Consultant (Ongoing)

Marc Philippon, MD

Arthrex: Own stock options in a privately held ineligible company (Ongoing)|Arthrex: Researcher (Ongoing)|bledsoe: Royalties (Ongoing)|ConMed: Royalties (Ongoing)|DJO: Royalties (Ongoing)|hydrocision: Speaker (Terminated, January 1, 2025)|MiS: Own stock or stock options in a publicly traded ineligible company (Ongoing)|NICE recovery systems: Speaker (Ongoing)|Ossur: Researcher (Ongoing)|siemens: Researcher (Ongoing)|Smith & Nephew: Consultant (Ongoing)|Smith & Nephew: Researcher (Ongoing)|Smith & Nephew: Royalties (Ongoing)

Matthew Provencher, MD

Anika Therapeutics: Consultant (Ongoing)|Anika Therapeutics: Paid Advisor (Ongoing)|Arthrex: Consultant (Ongoing)|Arthrex: Researcher (Ongoing)|Arthrex: Speaker (Ongoing)|Arthrosurface: Consultant (Ongoing)|Arthrosurface: Paid Advisor (Ongoing)|JRF Ortho: Consultant (Ongoing)|JRF Ortho: Paid Advisor (Ongoing)|JRF Ortho: Researcher (Ongoing)

Filippo Randelli, MD Prof. a.c.

Medacta: Consultant (Ongoing)|Medacta: Royalties (Ongoing)

Lauren Redler, MD

ConMed: Consultant (Ongoing)|Guidepoint: Consultant (Ongoing)|MoxImed: Consultant (Ongoing)

Dustin Richter, MD

Arthrex: Speaker (Ongoing)|Best in Class MD: Consultant (Ongoing)|Stryker: Consultant (Ongoing)

Scott Rodeo, MD

Advance Medical: Consultant (Ongoing)|Enovis: Consultant (Ongoing)|Overture: Own stock options in a privately held ineligible company (Ongoing)

Anthony Romeo, MD

Arthrex, Inc: Consultant (Ongoing)

Marc R. Safran, MD

Medacta: Consultant (Ongoing)|Medacta: Royalties (Ongoing)|Smith & Nephew: Consultant (Ongoing)|Smith & Nephew: Researcher (Ongoing)|Smith & Nephew: Royalties (Ongoing)|Top Shelf: Consultant (Ongoing)|Top Shelf: Royalties (Ongoing)|Vive Health: Royalties (Ongoing): Consultant (Ongoing)|Enovis: Royalties (Ongoing)|Smith & Nephew: Consultant (Ongoing)

Michael J. Scarcella, MD

Arthrex, Inc: Consultant (Ongoing)

Adam Seidl, MD

Enovis: Consultant (Ongoing)|Enovis: Royalties (Ongoing)|Smith & Nephew: Consultant (Ongoing)

Kevin Shea, MD

MedeLoop, Inc: Own stock options in a privately held ineligible company (Ongoing)|nView, INC: Own stock options in a privately held ineligible company (Ongoing)|Sarcio Inc: Own stock options in a privately held ineligible company (Ongoing)is: Consultant (Ongoing)|Enovis: Royalties (Ongoing)|Smith & Nephew: Consultant (Ongoing)

Andrew J. Sheean, MD

restor3d: Consultant (Ongoing)|Springbok Analytics: Own stock options in a privately held ineligible company (Ongoing)|Springbok Analytics: Paid Advisor (Ongoing)|Stryker Sports Medicine: Consultant (Ongoing)

Seth Sherman, MD

Allosource: Speaker (Ongoing)|Arcuro Medical: Consultant (Ongoing)|Arcuro Medical: Paid Advisor (Ongoing)|Arthrex: Consultant (Ongoing)|ConMed: Royalties (Ongoing)|DJO: Royalties (Ongoing)|Epicrispr BioTech: Own stock options in a privately held ineligible company (Ongoing)|Icarus: Own stock options in a privately held ineligible company (Ongoing)|JRF Ortho: Speaker(Ongoing)|Kinamed: Speaker (Ongoing)|Kyniska Robotics: Consultant (Ongoing)|Kyniska Robotics: Own stock options in a privately held ineligible company (Ongoing)|Kyniska Robotics: Paid Advisor (Ongoing)|LifeNet Health: Consultant (Ongoing)|MIACH: Speaker (Ongoing)|MoxImed: Consultant (Ongoing)|MoxImed: Own stock options in a privately held ineligible company (Ongoing)|MoxImed: Paid Advisor (Ongoing)|Octane Biotherapeutics: Speaker (Ongoing)|Organogenesis: Speaker (Ongoing)|Ossio: Speaker (Ongoing)|Reparel: Consultant (Ongoing)|Reparel: Own stock options in a privately held ineligible company (Ongoing)|Reparel: Paid Advisor (Ongoing)|Sarcio Inc: Consultant (Ongoing)|Sarcio Inc: Own stock options in a privately held ineligible company (Ongoing)|Sarcio Inc: Paid Advisor (Ongoing)|Smith & Nephew: Speaker (Ongoing)|Sparta Biomedical: Consultant (Ongoing)|Sparta Biomedical: Paid Advisor (Ongoing)|Sparta-Bioenthesis: Own stock options in a privately held ineligible company (Ongoing)|Vericel: Consultant (Ongoing)|Vivorte: Consultant (Ongoing)|Vivorte: Own stock options in a privately held ineligible company (Ongoing)|Vivorte: Paid Advisor (Ongoing)

Beth Shubin Stein, MD

Conmed: Speaker (Ongoing)

Karin Silbernagel, PT ATC PhD FAPTA

Enovis: Consultant (Ongoing)

Patrick Smith, MD

Arthrex, Inc: Consultant (Ongoing)|Arthrex, Inc: Researcher (Ongoing)|Arthrex, Inc: Royalties (Ongoing)|Arthrex, Inc: Speaker (Ongoing)|Spinal Simplicity: Own stock options in a privately held ineligible company (Ongoing)

Andrea Spiker, MD

Stryker Sports Medicine: Consultant (Ongoing)|Stryker Sports Medicine: Royalties (Ongoing)

Kurt Spindler, MD

Novo Pedics: Consultant (Ongoing)|PRO-T: Consultant (Ongoing)|Wake Forrest: Consultant (Ongoing)

Austin Stone, MD, PhD

Allosource: Consultant (Ongoing)|Allosource: Researcher (Ongoing)|Ossio: Consultant (Ongoing)|Ossio: Speaker (Ongoing)|Stryker Sports Medicine: Consultant (Ongoing)|Vericel: Speaker (Terminated, April 23, 2026)

Sabrina Strickland, MD

Bioventus LLC: Consultant (Ongoing)|Depuy Synthes: Speaker (Ongoing)|MoxImed: Consultant (Ongoing)|MoxImed: Own stock options in a privately held ineligible company (Ongoing)|MoxImed: Researcher (Ongoing)|Pacira: Speaker (Ongoing)|Smith & Nephew: Consultant (Ongoing)|Smith & Nephew: Researcher (Ongoing)|Smith & Nephew: Speaker (Ongoing)|Stryker: Own stock or stock options in a publicly traded ineligible company (Ongoing)

Miho Tanaka, MD, PhD

Arthrex Inc: Consultant (Ongoing)|Depuy Synthes: Consultant (Ongoing)|NIH/NIAMS: Researcher (Ongoing)|Vericel: Consultant (Ongoing)

Scott Tashman, MD

Arthrex: Researcher (Ongoing)|Canon Medical: Researcher (Ongoing)|Icarus: Researcher (Ongoing)

John M. Tokish, MD

Arthrex Inc: Consultant (Ongoing), Researcher (Ongoing), Royalties (Ongoing)

Keisuke Tsukada, MD., PhD.

FUJIFILM Corporation: Researcher (Ongoing)

Evan Vellios, MD

Advita: Consultant (Ongoing)

Nikhil Verma, MD

Stryker: Speaker (Ongoing)|Stryker: Royalties (Ongoing)|Tetrous: Consultant (Ongoing)|Tetrous: Own stock options in a privately held ineligible company (Ongoing)

Armando Vidal, MD

Bodycad: Consultant (Ongoing)|Bodycad: Own stock options in a privately held ineligible company (Ongoing)|Bodycad: Royalties (Ongoing)|Stryker Sports Medicine: Consultant (Ongoing)|Stryker Sports Medicine: Royalties (Ongoing)|Stryker Sports Medicine: Speaker (Ongoing)

Tim Wang, MD

Arthrex: Consultant (Ongoing)|Joint Restoration Foundation: Consultant (Ongoing)|MoxImed: Consultant (Ongoing)|Overture: Own stock options in a privately held ineligible company (Ongoing)

Brian Waterman, MD

Arthrex: Consultant (Ongoing)|Arthrex: Speaker (Ongoing)hnson and Johnson: Consultant (Ongoing)|Newclip: Consultant (Ongoing)|Smith & Nephew: Consultant (Ongoing)

Brian Werner, MD

Arthrex, Inc: Consultant (Ongoing)|Arthrex, Inc: Researcher (Ongoing)|Arthrex, Inc: Speaker (Ongoing): Consultant (Ongoing)|Arthrex: Speaker (Ongoing)

Robin West, MD

Arthrex: Speaker (Ongoing)|Caddix: Own stock options in a privately held ineligible company (Ongoing)|Q30: Own stock options in a privately held ineligible company (Ongoing)|Springbok Analytics: Own stock options in a privately held ineligible company (Ongoing)

Robert W. Westermann, MD

Johnson and Johnson: Consultant (Ongoing)|Newclip: Consultant (Ongoing)|Smith & Nephew: Consultant (Ongoing)

Brian Wolf, MD

ConMed: Consultant (Ongoing)|ConMed: Royalties (Ongoing)

Ivan Wong, MD, FRCS(C), Dip. Sports Med.,MACM, FAANA

Arthrex: Consultant (Ongoing)|Arthrex: Speaker (Ongoing)|Bioventus LLC: Speaker (Ongoing)|ConMed: Consultant (Ongoing)|ConMed: Speaker (Ongoing)|DePuy Mitek: Consultant (Ongoing)|DePuy Mitek: Speaker (Ongoing)|Smith & Nephew: Consultant (Ongoing)|Smith & Nephew: Speaker (Ongoing)|VALD: Consultant (Ongoing)|VALD: Speaker (Ongoing)

Gautam Yagnik, MD

Arthrex Inc: Consultant (Ongoing)|Arthrex Inc: Royalties (Ongoing)|Arthrex Inc: Speaker (Ongoing)

Adam Yanke, MD

Icarus: Own stock options in a privately held ineligible company (Ongoing)|Patient IQ: Consultant (Ongoing)|Patient IQ: Own stock options in a privately held ineligible company (Ongoing)|Sparta Biomedical: Consultant (Ongoing)|Sparta Biomedical: Own stock options in a privately held ineligible company (Ongoing)|Stryker: Consultant (Ongoing)|Stryker: Speaker (Ongoing)ex Inc: Consultant (Ongoing)|Arthrex Inc: Royalties (Ongoing)|Arthrex Inc: Speaker (Ongoing)

Stefano Zaffagnini, Prof.

Depuy Synthes: Consultant (Ongoing)|Finceramica: Consultant (Ongoing)|finceramica: Researcher (Ongoing)|Johnson and Johnson: Consultant (Ongoing)|Smith and Nephew: Consultant (Ongoing)

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, we have implemented measures to identify and mitigate relevant financial relationships. All individuals in control of content have disclosed their financial relationships with ineligible companies within the past 24 months. These relationships have been reviewed and mitigated.

ORIGINAL RELEASE DATE: 8/1/2026
EXPIRATION DATE: 7/31/2029

Summary

Availability:

On-Demand

Expires on Jul 31, 2029

Cost:

Member: $499.00
Resident/Fellow Member: $499.00
Affiliate Member: $499.00
Non-Member: $599.00

Credit Offered:

31 CME Credits

31 Category A CEU Credits

Contains:

3 Courses